Your browser doesn't support javascript.
loading
RIG-I activation is critical for responsiveness to checkpoint blockade.
Heidegger, Simon; Wintges, Alexander; Stritzke, Florian; Bek, Sarah; Steiger, Katja; Koenig, Paul-Albert; Göttert, Sascha; Engleitner, Thomas; Öllinger, Rupert; Nedelko, Tatiana; Fischer, Julius C; Makarov, Vladimir; Winter, Christof; Rad, Roland; van den Brink, Marcel R M; Ruland, Jürgen; Bassermann, Florian; Chan, Timothy A; Haas, Tobias; Poeck, Hendrik.
Afiliação
  • Heidegger S; Department of Medicine III, School of Medicine, Technical University of Munich, Munich, Germany. simon.heidegger@tum.de hendrik.poeck@tum.de.
  • Wintges A; Center for Translational Cancer Research (TranslaTUM), School of Medicine, Technical University of Munich, Munich, Germany.
  • Stritzke F; Department of Medicine III, School of Medicine, Technical University of Munich, Munich, Germany.
  • Bek S; Department of Medicine III, School of Medicine, Technical University of Munich, Munich, Germany.
  • Steiger K; Center for Translational Cancer Research (TranslaTUM), School of Medicine, Technical University of Munich, Munich, Germany.
  • Koenig PA; Department of Medicine III, School of Medicine, Technical University of Munich, Munich, Germany.
  • Göttert S; Institute of Pathology, School of Medicine, Technical University of Munich, Munich, Germany.
  • Engleitner T; German Cancer Consortium (DKTK), Partner-site Munich and German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Öllinger R; German Cancer Consortium (DKTK), Partner-site Munich and German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Nedelko T; Institute of Clinical Chemistry and Pathobiochemistry, School of Medicine, Technical University of Munich, Munich, Germany.
  • Fischer JC; Core Facility Nanobodies, University of Bonn, Bonn, Germany.
  • Makarov V; Department of Medicine III, School of Medicine, Technical University of Munich, Munich, Germany.
  • Winter C; Center for Translational Cancer Research (TranslaTUM), School of Medicine, Technical University of Munich, Munich, Germany.
  • Rad R; Center for Translational Cancer Research (TranslaTUM), School of Medicine, Technical University of Munich, Munich, Germany.
  • van den Brink MRM; Institute of Molecular Oncology and Functional Genomics, School of Medicine, Technical University of Munich, Munich, Germany.
  • Ruland J; Center for Translational Cancer Research (TranslaTUM), School of Medicine, Technical University of Munich, Munich, Germany.
  • Bassermann F; Institute of Molecular Oncology and Functional Genomics, School of Medicine, Technical University of Munich, Munich, Germany.
  • Chan TA; Department of Medicine III, School of Medicine, Technical University of Munich, Munich, Germany.
  • Haas T; Center for Translational Cancer Research (TranslaTUM), School of Medicine, Technical University of Munich, Munich, Germany.
  • Poeck H; Department of Medicine III, School of Medicine, Technical University of Munich, Munich, Germany.
Sci Immunol ; 4(39)2019 09 13.
Article em En | MEDLINE | ID: mdl-31519811
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Proteína DEAD-box 58 / Melanoma Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Animals / Humans Idioma: En Revista: Sci Immunol Ano de publicação: 2019 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Proteína DEAD-box 58 / Melanoma Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Animals / Humans Idioma: En Revista: Sci Immunol Ano de publicação: 2019 Tipo de documento: Article